4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid TumorsLocally Advanced Solid TumorRecruitingPhase 12026-09-25NCT06349408
A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell LymphomaB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 1 / Phase 22025-08-15NCT07124936
Neoadjuvant Immunochemotherapy in PD-L1-negative LACCFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorderRecruitingPhase 22025-03-20NCT06288360
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACCFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorderRecruitingPhase 2 / Phase 32024-10-30NCT06288373